Project breathes new life into care for patients with interstitial lung disease
Tim Brady received life-altering news in 2017 that he has interstitial lung disease (ILD). What he didn’t receive at the...
interstitial
AI-Enhanced Approaches to Interstitial Lung Disease: A Review of Machine Learning Advances
Key Points 1. Interstitial lung diseases (ILD) cause significant morbidity, yet diagnosis is often delayed. AI offers potential to improve...
Empowering interstitial lung disease patients with digital health tech
Dr. Bipin Patel, CEO and Founder of electronRx, a deep-tech startup developing novel chronic disease and hospital patient management solutions,...
Research aims to improve interstitial lung disease prognosis with new imaging agent
Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker...
Phase II PREDICT-ILD Imaging Study Commences in Interstitial Lung Disease
LONDON, Sept. 10, 2024 /PRNewswire/ -- Serac Healthcare Limited ("Serac Healthcare" or "the Company"), a clinical radiopharmaceutical company developing innovative...
